Published in AIDS on October 01, 2008
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One (2010) 1.73
Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol (2010) 1.65
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med (2015) 1.61
Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice. AIDS Res Hum Retroviruses (2012) 1.52
Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen. PLoS One (2012) 1.42
Targeting Trojan Horse leukocytes for HIV prevention. AIDS (2010) 1.40
Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol (2011) 1.40
Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology (2009) 1.37
Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J Transl Med (2011) 1.36
Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol (2013) 1.22
The role of sex hormones in immune protection of the female reproductive tract. Nat Rev Immunol (2015) 1.21
Women and HIV in Sub-Saharan Africa. AIDS Res Ther (2013) 1.20
Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol (2013) 1.09
Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women. PLoS One (2012) 1.08
SHIV susceptibility changes during the menstrual cycle of pigtail macaques. J Med Primatol (2014) 1.05
Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites. J Virol (2012) 1.04
Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol (2010) 1.04
Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study. PLoS One (2014) 1.02
Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PLoS One (2013) 1.01
Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route. Clin Vaccine Immunol (2012) 0.99
Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV. J Immunol (2010) 0.97
Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility. J Virol (2015) 0.96
Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells. PLoS One (2010) 0.96
Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract. Proteome Sci (2010) 0.96
Phenotype and functionality of CD4+ and CD8+ T cells in the upper reproductive tract of healthy premenopausal women. Am J Reprod Immunol (2013) 0.96
Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens. Am J Reprod Immunol (2014) 0.96
Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS One (2011) 0.95
Caveats associated with the use of human cervical tissue for HIV and microbicide research. AIDS (2010) 0.95
Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus. Dis Model Mech (2013) 0.94
In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa. PLoS One (2011) 0.94
Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission. PLoS One (2014) 0.93
Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. Vaccine (2013) 0.92
Implications of HIV PrEP trials results. AIDS Res Hum Retroviruses (2010) 0.92
HSV-2-driven increase in the expression of α4β7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infection. PLoS Pathog (2014) 0.92
Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, α-/β-defensins and TLRs. Innate Immun (2012) 0.91
Optical coherence tomography compared with colposcopy for assessment of vaginal epithelial damage: a randomized controlled trial. Obstet Gynecol (2011) 0.91
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention. Clin Vaccine Immunol (2015) 0.90
Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells. Am J Reprod Immunol (2013) 0.90
Pregnancy-induced changes in immune protection of the genital tract: defining normal. Am J Obstet Gynecol (2013) 0.89
The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception. MBio (2015) 0.89
Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture. PLoS One (2014) 0.88
New approaches to making the microenvironment of the female reproductive tract hostile to HIV. Am J Reprod Immunol (2011) 0.88
Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells. J Virol (2012) 0.88
Sex Differences in HIV Prevalence Persist over Time: Evidence from 18 Countries in Sub-Saharan Africa. PLoS One (2016) 0.88
Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications. Am J Reprod Immunol (2011) 0.87
Cell-mediated immunity to HIV in the female reproductive tract. J Reprod Immunol (2009) 0.87
Sexual risk factors for partner age discordance in adolescent girls and their male partners. J Clin Nurs (2013) 0.87
Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential. J Immunol (2016) 0.86
Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract. PLoS One (2012) 0.86
Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLoS One (2013) 0.86
Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract. PLoS Pathog (2014) 0.86
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA. J Immunol (2011) 0.86
Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus. PLoS One (2010) 0.86
Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N. J Virol (2012) 0.86
Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation. Am J Reprod Immunol (2012) 0.84
In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women. Am J Obstet Gynecol (2012) 0.84
Personalized Biobehavioral HIV Prevention for Women and Adolescent Girls. Glob Adv Health Med (2013) 0.83
Progestin-Containing Contraceptives Alter Expression of Host Defense-Related Genes of the Endometrium and Cervix. Reprod Sci (2015) 0.82
Effect of oestradiol and pathogen-associated molecular patterns on class II-mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract. Immunology (2012) 0.82
Links among inflammation, sexual activity and ovulation: Evolutionary trade-offs and clinical implications. Evol Med Public Health (2015) 0.81
Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts. PLoS One (2010) 0.81
Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV. Mucosal Immunol (2016) 0.81
Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography. Am J Obstet Gynecol (2013) 0.81
Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety. J Acquir Immune Defic Syndr (2012) 0.81
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women. AIDS (2016) 0.80
Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors. Mol Cell Endocrinol (2012) 0.80
Cataloguing of Potential HIV Susceptibility Factors during the Menstrual Cycle of Pig-Tailed Macaques by Using a Systems Biology Approach. J Virol (2015) 0.80
Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary. AIDS Res Hum Retroviruses (2012) 0.80
Relationship of menstrual cycle and vaginal infection in female rhesus macaques challenged with repeated, low doses of SIVmac251. J Med Primatol (2015) 0.79
Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study. PLoS One (2015) 0.79
Estrogen receptor α antagonists mediate changes in CCL20 and CXCL1 secretions in the murine female reproductive tract. Am J Reprod Immunol (2012) 0.79
How can we design better vaccines to prevent HIV infection in women? Front Microbiol (2014) 0.79
Mouse endometrial stromal cells and progesterone inhibit the activation and regulate the differentiation and antibody secretion of mouse B cells. Int J Clin Exp Pathol (2013) 0.78
Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women. Am J Reprod Immunol (2014) 0.78
A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model. J Med Primatol (2014) 0.78
Clinical parameters essential to methodology and interpretation of mucosal responses. Am J Reprod Immunol (2011) 0.78
Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract. Antimicrob Agents Chemother (2014) 0.78
Novel three dimensional human endocervix cultures respond to 28-day hormone treatment. Endocrinology (2015) 0.78
Beyond the Pap Smear: Gender-responsive HIV Care for Women. Yale J Biol Med (2016) 0.77
What explains gender inequalities in HIV/AIDS prevalence in sub-Saharan Africa? Evidence from the demographic and health surveys. BMC Public Health (2016) 0.77
Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success? J Int AIDS Soc (2015) 0.77
Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses. Clin Transl Immunology (2015) 0.77
Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women. AIDS Res Hum Retroviruses (2016) 0.77
Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women. Am J Reprod Immunol (2015) 0.77
The role of sex hormones and the tissue environment in immune protection against HIV in the female reproductive tract. Am J Reprod Immunol (2014) 0.77
Macaque models of enhanced susceptibility to HIV. Virol J (2015) 0.77
Exploring Genitoanal Injury and HIV Risk Among Women: Menstrual Phase, Hormonal Birth Control, and Injury Frequency and Prevalence. J Acquir Immune Defic Syndr (2016) 0.76
Challenges in mucosal HIV vaccine development: lessons from non-human primate models. Viruses (2014) 0.76
Nondaily preexposure prophylaxis for HIV prevention. Curr Opin HIV AIDS (2016) 0.76
Estradiol regulation of constitutive and keratinocyte growth factor-induced CCL20 and CXCL1 secretion by mouse uterine epithelial cells. Am J Reprod Immunol (2014) 0.76
Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model. J Virol (2015) 0.76
Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV Infection. Am J Reprod Immunol (2015) 0.76
Highly-Exposed HIV-1 seronegative Female Commercial Sex Workers sustain in their genital mucosa increased frequencies of tolerogenic myeloid and regulatory T-cells. Sci Rep (2017) 0.75
Quotidian changes of genital tract cytokines in human immunodeficiency virus-1-infected women during the menstrual cycle. Open Forum Infect Dis (2014) 0.75
Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract. Curr HIV/AIDS Rep (2016) 0.75
Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women. Am J Reprod Immunol (2016) 0.75
Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro. AIDS (2015) 0.75
Characterization of immune cells and infection by HIV in human ovarian tissues. Am J Reprod Immunol (2017) 0.75
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol (2005) 5.92
Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev (2005) 3.01
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst (2003) 2.58
Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS (2002) 2.33
Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol (1998) 2.19
The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol (2007) 2.03
HIV and sexually transmitted diseases: lethal synergy. Top HIV Med (2004) 1.84
Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol (2005) 1.83
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol (2005) 1.82
PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS (2007) 1.75
The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis (2007) 1.75
Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol (1997) 1.72
Probabilities of sexual HIV-1 transmission. AIDS (1996) 1.64
CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol (1997) 1.62
Induction of regulatory T cells by physiological level estrogen. J Cell Physiol (2008) 1.59
Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis (2002) 1.57
Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reprod Immunol (2008) 1.52
Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol (2003) 1.46
Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology (2004) 1.38
Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses (1998) 1.38
AIDS research. Promising AIDS vaccine's failure leaves field reeling. Science (2007) 1.38
Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol (1997) 1.31
The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod (1996) 1.30
Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture. Mucosal Immunol (2008) 1.30
TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol (2000) 1.21
Sperm transport from the external cervical os to the fallopian tubes in women: a time and quantitation study. Fertil Steril (1973) 1.20
Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J Reprod Immunol (2002) 1.15
Lipopolysaccharide-induced IL-1 beta production by human uterine macrophages up-regulates uterine epithelial cell expression of human beta-defensin 2. J Immunol (2006) 1.14
The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol (1997) 1.13
Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol (2004) 1.12
Phase III anti-HIV microbicide trial in Africa and India stopped as preliminary results show gel may increase risk of infection. Euro Surveill (2007) 1.12
Inhibition of human neutrophil degranulation by transforming growth factor-beta1. Clin Exp Immunol (2007) 1.05
Interaction of human immunodeficiency virus with human sperm in vitro. J Acquir Immune Defic Syndr (1988) 1.00
Microbicide trial screeches to a halt. J Clin Invest (2007) 0.99
Variations in the levels of secretory component in human uterine fluid during the menstrual cycle. J Steroid Biochem (1984) 0.98
Human immunodeficiency virus-specific and CD3-redirected cytotoxic T lymphocyte activity in the human female reproductive tract: lack of correlation between mucosa and peripheral blood. J Infect Dis (2001) 0.94
AIDS research. Promising prevention interventions perform poorly in trials. Science (2007) 0.94
MHC class II expression and antigen presentation by human endometrial cells. J Steroid Biochem Mol Biol (2001) 0.93
Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1. Biol Reprod (1998) 0.93
Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848). Antiviral Res (2005) 0.90
Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. AIDS Res Hum Retroviruses (1996) 0.89
Effect of the menstrual cycle on immunological parameters in the human female reproductive tract. J Acquir Immune Defic Syndr (2005) 0.88
Hormonal contraception and incident HIV-1 infection: new insight and continuing challenges. AIDS (2007) 0.88
Polarized uterine epithelial cells preferentially present antigen at the basolateral surface: role of stromal cells in regulating class II-mediated epithelial cell antigen presentation. J Immunol (2005) 0.88
Estradiol attenuates lipopolysaccharide-induced CXC chemokine ligand 8 production by human peripheral blood monocytes. J Immunol (2007) 0.88
Human fallopian tube neutrophils--a distinct phenotype from blood neutrophils. Am J Reprod Immunol (2006) 0.86
Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am J Reprod Immunol (2006) 0.86
The innate immune system: a repository for future drugs? Expert Rev Anti Infect Ther (2007) 0.84
Effect of oestradiol and pathogen-associated molecular patterns on class II-mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract. Immunology (2012) 0.82
Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev (2005) 3.01
Surviving sepsis in low-income and middle-income countries: new directions for care and research. Lancet Infect Dis (2009) 2.47
Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology (2004) 1.87
Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol (2005) 1.83
PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS (2007) 1.75
Prognostication of post-cardiac arrest coma: early clinical and electroencephalographic predictors of outcome. Intensive Care Med (2015) 1.74
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One (2010) 1.73
Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol (2010) 1.65
Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands. J Leukoc Biol (2010) 1.59
Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis (2002) 1.57
Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice. AIDS Res Hum Retroviruses (2012) 1.52
Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol (2011) 1.40
Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology (2004) 1.38
Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology (2009) 1.37
Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun (2004) 1.36
Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol (2009) 1.32
CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol (2009) 1.18
Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol (2004) 1.17
Lipopolysaccharide-induced IL-1 beta production by human uterine macrophages up-regulates uterine epithelial cell expression of human beta-defensin 2. J Immunol (2006) 1.14
Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol (2004) 1.12
Unique characteristics of NK cells throughout the human female reproductive tract. Clin Immunol (2007) 1.11
CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys. Infect Immun (2005) 1.11
Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS One (2009) 1.10
Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C). Hum Reprod (2006) 1.09
Innate and adaptive anti-HIV immune responses in the female reproductive tract. J Reprod Immunol (2013) 1.09
TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol (2006) 1.05
Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis (2004) 1.03
Effect of mouse uterine stromal cells on epithelial cell transepithelial resistance (TER) and TNFalpha and TGFbeta release in culture. Biol Reprod (2003) 1.02
The innate immune system: gatekeeper to the female reproductive tract. Immunology (2004) 1.01
Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse. Am J Reprod Immunol (2006) 1.01
Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PLoS One (2013) 1.01
Expression of Toll-like receptors (TLR) and responsiveness to TLR agonists by polarized mouse uterine epithelial cells in culture. Biol Reprod (2006) 0.99
Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12. J Virol (2009) 0.99
Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens. Curr Womens Health Rev (2008) 0.98
IL-1beta-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type I in uterine epithelial cells. J Immunol (2005) 0.96
Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells. PLoS One (2010) 0.96
Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity. AIDS Res Hum Retroviruses (2012) 0.96
Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens. Am J Reprod Immunol (2014) 0.96
Synergy between IL-8 and GM-CSF in reproductive tract epithelial cell secretions promotes enhanced neutrophil chemotaxis. Cell Immunol (2004) 0.95
Estradiol modulation of hepatocyte growth factor by stromal fibroblasts in the female reproductive tract. Fertil Steril (2009) 0.94
Effect of oestradiol on PAMP-mediated CCL20/MIP-3 alpha production by mouse uterine epithelial cells in culture. Immunology (2006) 0.94
Antiviral responses of human Fallopian tube epithelial cells to toll-like receptor 3 agonist poly(I:C). Fertil Steril (2007) 0.93
Secretion of monocyte chemotactic protein-1 by human uterine epithelium directs monocyte migration in culture. Fertil Steril (2005) 0.92
Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, α-/β-defensins and TLRs. Innate Immun (2012) 0.91
Migration inhibitory factor secretion by polarized uterine epithelial cells is enhanced in response to the TLR3 agonist poly (I:C). Am J Reprod Immunol (2005) 0.91
Effects of estradiol on lipopolysaccharide and Pam3Cys stimulation of CCL20/macrophage inflammatory protein 3 alpha and tumor necrosis factor alpha production by uterine epithelial cells in culture. Infect Immun (2005) 0.91
Innate immunity in the vagina (part I): estradiol inhibits HBD2 and elafin secretion by human vaginal epithelial cells. Am J Reprod Immunol (2013) 0.90
Effect of oestradiol on mouse uterine epithelial cell tumour necrosis factor-alpha release is mediated through uterine stromal cells. Immunology (2005) 0.89
Effect of tenofovir on nucleotidases and cytokines in HIV-1 target cells. PLoS One (2013) 0.89
Human uterine NK cells interact with uterine macrophages via NKG2D upon stimulation with PAMPs. Am J Reprod Immunol (2009) 0.89
New approaches to making the microenvironment of the female reproductive tract hostile to HIV. Am J Reprod Immunol (2011) 0.88
Estradiol attenuates lipopolysaccharide-induced CXC chemokine ligand 8 production by human peripheral blood monocytes. J Immunol (2007) 0.88
Paracrine mediators of mouse uterine epithelial cell transepithelial resistance in culture. J Reprod Immunol (2005) 0.88
Uterine epithelial cells specifically induce interferon-stimulated genes in response to polyinosinic-polycytidylic acid independently of estradiol. PLoS One (2012) 0.87
Human fallopian tube neutrophils--a distinct phenotype from blood neutrophils. Am J Reprod Immunol (2006) 0.86
Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract. PLoS One (2012) 0.86
Effect of Escherichia coli and Lactobacillus rhamnosus on macrophage inflammatory protein 3 alpha, tumor necrosis factor alpha, and transforming growth factor beta release by polarized rat uterine epithelial cells in culture. Infect Immun (2004) 0.86
Effect of estradiol on mouse uterine epithelial cell transepithelial resistance (TER). Am J Reprod Immunol (2004) 0.86
Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLoS One (2013) 0.86
Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am J Reprod Immunol (2006) 0.86
HIV-1 infection of the female reproductive tract. Curr HIV/AIDS Rep (2005) 0.85
Functional expression of pattern recognition receptors in tissues of the human female reproductive tract. J Reprod Immunol (2009) 0.85
Effects of menstrual cycle status and gender on human neutrophil phenotype. Am J Reprod Immunol (2007) 0.85
Estradiol regulates MICA expression in human endometrial cells. Clin Immunol (2008) 0.84
In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women. Am J Obstet Gynecol (2012) 0.84
Modulation of hepatocyte growth factor secretion in human female reproductive tract stromal fibroblasts by poly (I:C) and estradiol. Am J Reprod Immunol (2011) 0.84
Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation. Am J Reprod Immunol (2012) 0.84
Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity. J Infect Dis (2003) 0.84
A subset of human uterine endometrial macrophages is alternatively activated. Am J Reprod Immunol (2012) 0.82
Sex hormone modulation of human uterine epithelial cell immune responses. Integr Comp Biol (2006) 0.82
A multiplexed assay to detect antimicrobial peptides in biological fluids and cell secretions. J Immunol Methods (2013) 0.82
Antigen presentation by human uterine epithelial cells to autologous T cells. Am J Reprod Immunol (2006) 0.82
Effect of oestradiol and pathogen-associated molecular patterns on class II-mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract. Immunology (2012) 0.82
NK cell function in the human female reproductive tract. Am J Reprod Immunol (2007) 0.81
Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions. Am J Reprod Immunol (2014) 0.81